Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK058881-01A2S1
Application #
6692792
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mullins, Christopher V
Project Start
2002-04-10
Project End
2007-03-31
Budget Start
2002-04-10
Budget End
2003-03-31
Support Year
1
Fiscal Year
2003
Total Cost
$25,725
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Zhang, Hongyong; Aina, Olulanu H; Lam, Kit S et al. (2012) Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach. Urol Oncol 30:635-45
Zhang, Dianzhong; Hudson, Amber E; Delostrinos, Catherine F et al. (2011) Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream. Am J Physiol Renal Physiol 300:F475-87
Hudson, Amber E; Carmean, Nicole; Bassuk, James A (2007) Extracellular matrix protein coatings for facilitation of urothelial cell attachment. Tissue Eng 13:2219-25
Kosman, Jeffrey; Carmean, Nicole; Leaf, Elizabeth M et al. (2007) The motif of SPARC that inhibits DNA synthesis is not a nuclear localization signal. J Mol Biol 371:883-901
Carmean, N; Kosman, J W; Leaf, E M et al. (2007) Immortalization of human urothelial cells by human papillomavirus type 16 E6 and E7 genes in a defined serum-free system. Cell Prolif 40:166-84
Delostrinos, Catherine F; Hudson, Amber E; Feng, Waldo C et al. (2006) The C-terminal Ca2+-binding domain of SPARC confers anti-spreading activity to human urothelial cells. J Cell Physiol 206:211-20
Hudson, Amber E; Feng, Waldo C; Delostrinos, Catherine F et al. (2005) Spreading of embryologically distinct urothelial cells is inhibited by SPARC. J Cell Physiol 202:453-63